BioSpace News Archive

Press Releases

Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors

October 20, 2025
·
5 min read
Press Releases

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

October 20, 2025
·
7 min read
Press Releases

IMUNON Invited to Present PlaCCine® DNA Technology Proof-of-Concept Data in Platform Presentations at Leading Vaccine Conferences

October 20, 2025
·
5 min read
Press Releases

Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01

October 20, 2025
·
7 min read
Press Releases

Agios’ PYRUKYND® (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia

October 20, 2025
·
10 min read
Press Releases

Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population

October 20, 2025
·
14 min read
Press Releases

Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis

October 20, 2025
·
5 min read
Press Releases

Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025

October 20, 2025
·
3 min read
Press Releases

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

October 20, 2025
·
9 min read
Press Releases

Lilly’s Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

October 20, 2025
·
24 min read